Spots Global Cancer Trial Database for nelarabine
Every month we try and update this database with for nelarabine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) | NCT06210750 | T Acute Lymphob... T Lymphoblastic... | Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Calaspargase Pe... Computed Tomogr... Cyclophosphamid... Cytarabine Daunorubicin Dexamethasone Doxorubicin Echocardiograph... Lumbar Puncture Mercaptopurine Methotrexate Multigated Acqu... Navitoclax Nelarabine Pegaspargase Positron Emissi... Thioguanine Venetoclax Vincristine X-Ray Imaging | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma | NCT00408005 | T Acute Lymphob... T Lymphoblastic... | Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul... | 1 Year - 30 Years | National Cancer Institute (NCI) | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma | NCT02763384 | T-Acute Lymphob... Adult T Lymphob... | BL-8040 Nelarabine | 18 Years - | Washington University School of Medicine | |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma | NCT00408005 | T Acute Lymphob... T Lymphoblastic... | Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul... | 1 Year - 30 Years | National Cancer Institute (NCI) | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | NCT03328104 | Lymphoblastic L... Lymphoblastic L... | Everolimus Nelarabine Cyclophosphamid... Etoposide | 2 Years - 29 Years | Emory University | |
| 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) | NCT00684619 | T-ALL, T-NHL (L... | Nelarabine | 18 Years - | Goethe University | |
| Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old) | NCT02619630 | T-cell Adult Ac... | nelarabine | 18 Years - 59 Years | Assistance Publique - Hôpitaux de Paris | |
| Observational Study of Nelarabine in Children and Young Adults | NCT00866671 | Leukaemia, Lymp... | nelarabine | - 21 Years | GlaxoSmithKline | |
| Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma | NCT03117751 | Acute Lymphobla... Acute Lymphobla... | Prednisone Vincristine Daunorubicin Pegaspargase Erwinase® Cyclophosphamid... Cytarabine Mercaptopurine Dasatinib Methotrexate Blinatumomab Ruxolitinib Bortezomib Dexamethasone Doxorubicin Etoposide Clofarabine Vorinostat Idarubicin Nelarabine Thioguanine Asparaginase Er... Calaspargase Pe... | 1 Year - 18 Years | St. Jude Children's Research Hospital | |
| 506U78 in Treating Patients With Refractory Hematologic Cancer | NCT00002970 | Recurrent Child... Recurrent Child... T-cell Childhoo... | nelarabine methotrexate cytarabine therapeutic hyd... | - 21 Years | National Cancer Institute (NCI) | |
| Observational Study of Nelarabine in Children and Young Adults | NCT00866671 | Leukaemia, Lymp... | nelarabine | - 21 Years | GlaxoSmithKline | |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL | NCT00981799 | Relapsed T-Cell... Relapsed T-Cell... | Nelarabine Etoposide Cyclophosphamid... Methotrexate Filgrastim | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma | NCT00003837 | Leukemia Lymphoma | nelarabine | 16 Years - | National Cancer Institute (NCI) | |
| S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia | NCT00006020 | Leukemia | nelarabine | 16 Years - | SWOG Cancer Research Network | |
| 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents | NCT00003635 | Leukemia | nelarabine | 18 Years - | National Cancer Institute (NCI) | |
| Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL | NCT00981799 | Relapsed T-Cell... Relapsed T-Cell... | Nelarabine Etoposide Cyclophosphamid... Methotrexate Filgrastim | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | NCT03328104 | Lymphoblastic L... Lymphoblastic L... | Everolimus Nelarabine Cyclophosphamid... Etoposide | 2 Years - 29 Years | Emory University | |
| Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT00501826 | T Acute Lymphob... T Lymphoblastic... | Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Venetoclax Vincristine Sul... | - | M.D. Anderson Cancer Center | |
| 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents | NCT00003635 | Leukemia | nelarabine | 18 Years - | National Cancer Institute (NCI) | |
| Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg | NCT01376115 | Cancer | Nelarabine | - | Novartis | |
| Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT01085617 | Leukemia Mucositis Oral Complicati... | palifermin rituximab cyclophosphamid... cytarabine daunorubicin hy... etoposide fludarabine pho... imatinib mesyla... melphalan mercaptopurine methotrexate nelarabine pegaspargase vincristine sul... allogeneic hema... total-body irra... | 25 Years - 65 Years | University College, London | |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | NCT03328104 | Lymphoblastic L... Lymphoblastic L... | Everolimus Nelarabine Cyclophosphamid... Etoposide | 2 Years - 29 Years | Emory University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
